Postmarketing Safety of Transcranial Magnetic Stimulation
The Journal of Clinical Psychiatry · 11.02.2026 · 87 (2)
DOI: 10.4088/jcp.25m16155 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift The Journal of Clinical Psychiatry, online erschienen am 11.02.2026. Verfasst von Ali Imam Awan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Maimonides Medical Center, Brooklyn, New York. Hauptthemen laut MEDLINE: Transcranial Magnetic Stimulation, Product Surveillance, Postmarketing. Die Arbeit wurde bisher 4-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Maimonides Medical Center, Brooklyn, New York.
- Corresponding Author: Ali Imam Awan, MBBS, Maimonides Medical Center, Psychiatry, 4802 10th Ave, Brooklyn, NY 11219 (aawan@maimo.org).
- King Edward Medical University, Lahore, Pakistan.
- Lahore General Hospital, Lahore, Pakistan.
- Mayo Clinic, Scottsdale, Arizona.
Zitieren
APA
Awan, A. I., Waheed, N., Zahra, R., Dad, A., & Singh, D. (2026). Postmarketing Safety of Transcranial Magnetic Stimulation. The Journal of Clinical Psychiatry, 87(2). https://doi.org/10.4088/jcp.25m16155
Vancouver
Awan AI, Waheed N, Zahra R, Dad A, Singh D. Postmarketing Safety of Transcranial Magnetic Stimulation. The Journal of Clinical Psychiatry. 2026;87(2). doi:10.4088/jcp.25m16155
BibTeX
@article{Awan2026,
author = {Awan, Ali Imam and Waheed, Nida and Zahra, Rida and Dad, Allah and Singh, Deepan},
title = {Postmarketing Safety of Transcranial Magnetic Stimulation},
journal = {The Journal of Clinical Psychiatry},
year = {2026},
volume = {87},
number = {2},
doi = {10.4088/jcp.25m16155}
}
EUVIMED